A first-in-human study of MSB-2311

Trial Profile

A first-in-human study of MSB-2311

Phase of Trial: Phase I

Latest Information Update: 07 Mar 2017

At a glance

  • Drugs MSB 2311 (Primary)
  • Indications Cancer
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 07 Mar 2017 New trial record
    • 23 Feb 2017 According to a MabSpace Biosciences media release, the company is planning to start this study later this year.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top